Abstract
Cachexia is a complex syndrome. The main components of this pathological state are anorexia and metabolic abnormalities such as glucose intolerance, fat depletion, and muscle protein catabolism among others. The aim of the present article is to review the different therapeutic approaches that have been designed to fight and counteract muscle wasting in different pathological states such as cancer, AIDS and chronic heart failure.
Keywords: cachexia, cancer, aids, chronic heart failure, anorexia, tumor therapy
Current Drug Targets
Title: The Pharmacological Treatment of Cachexia
Volume: 5 Issue: 3
Author(s): Josep M. Argiles, Vanessa Almendro, Sílvia Busquets and Francisco J. Lopez-Soriano
Affiliation:
Keywords: cachexia, cancer, aids, chronic heart failure, anorexia, tumor therapy
Abstract: Cachexia is a complex syndrome. The main components of this pathological state are anorexia and metabolic abnormalities such as glucose intolerance, fat depletion, and muscle protein catabolism among others. The aim of the present article is to review the different therapeutic approaches that have been designed to fight and counteract muscle wasting in different pathological states such as cancer, AIDS and chronic heart failure.
Export Options
About this article
Cite this article as:
Argiles M. Josep, Almendro Vanessa, Busquets Sílvia and Lopez-Soriano J. Francisco, The Pharmacological Treatment of Cachexia, Current Drug Targets 2004; 5 (3) . https://dx.doi.org/10.2174/1389450043490505
DOI https://dx.doi.org/10.2174/1389450043490505 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Autocrine/Paracrine Loop After Myocardial Stretch: Mineralocorticoid Receptor Activation
Current Cardiology Reviews Editorial (Hot Topic: No Reflow: What’s in a Name?)
Current Pharmaceutical Design Pharmaceuticals and Cosmeceuticals Based on Soft Nanotechnology Techniques with Antioxidative, Immunostimulative and other Therapeutic Activities
Recent Patents on Nanotechnology Synthesis and Inhibitory Effects of Some Novel 1,3-diarylprop-2-en-1-one Analogues in Foxp3 Expression: A Novel Class of Anti-cancer Candidates
Medicinal Chemistry Therapies Targeting Innate Immunity for Fighting Inflammation in Atherosclerosis
Current Pharmaceutical Design Effectiveness of Resveratrol Against Cardiovascular Disease
Mini-Reviews in Organic Chemistry Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of Dementia
Recent Patents on CNS Drug Discovery (Discontinued) Antioxidant Enzyme Mimics with Synergism
Mini-Reviews in Medicinal Chemistry ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery Glucagon-Like Peptide 1 and the Cardiovascular System
Current Diabetes Reviews Insulin Resistance in the Early Stages of Renal Failure: Implications for Cardiovascular Risk
Current Diabetes Reviews microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets Drug release from ordered mesoporous silicas
Current Pharmaceutical Design On the Structural Basis of the Hypertensive Properties of Angiotensin II: A Solved Mystery or a Controversial Issue?
Current Topics in Medicinal Chemistry Women’s Ginseng (Angelica sinensis): An Ethnopharmacological Dossier
Current Traditional Medicine Overview and Findings from the Rush Memory and Aging Project
Current Alzheimer Research Dietary Phytoestrogens: Neuroprotective Role in Parkinson’s Disease
Current Neurovascular Research Interatrial Block in the Modern Era
Current Cardiology Reviews HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design